Rayzebio, Inc.
Clinical trials sponsored by Rayzebio, Inc., explained in plain language.
-
New hope for tough lung cancer? early trial combines targeted drug with standard care
Disease control OngoingThis early-phase study tests a new drug called RYZ101 added to standard chemotherapy and immunotherapy for people with a specific type of advanced lung cancer (extensive stage small cell lung cancer) that has a certain marker (SSTR+). The main goals are to find the safest dose an…
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New targeted radiation therapy shows promise for tough breast cancer
Disease control OngoingThis early-phase trial tests a drug called RYZ101 in people with a specific type of advanced breast cancer (ER+, HER2-) that has not responded to other treatments. The drug delivers radiation directly to cancer cells that have a certain marker (SSTR). The goal is to see if it is …
Phase: PHASE1, PHASE2 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC